Goodwill of Theriva Biologics, Inc. from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Theriva Biologics, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • Theriva Biologics, Inc. Goodwill for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Theriva Biologics, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$5,700,000 -100% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q2 2024 $1,465,000 -$4,156,000 -74% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $5,573,000 -$44,000 -0.78% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,700,000 +$175,000 +3.2% 31 Dec 2023 10-K 12 Mar 2026 2025 FY
Q3 2023 $5,460,000 +$237,000 +4.5% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $5,621,000 -$597,000 -9.6% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $5,617,000 -$192,000 -3.3% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,525,000 +$5,525,000 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $5,223,000 30 Sep 2022 10-K 30 Mar 2023 2022 FY
Q2 2022 $6,218,000 30 Jun 2022 10-K 30 Mar 2023 2022 FY
Q1 2022 $5,809,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-Q 08 Aug 2023 2023 Q2
Q3 2011 $178,229 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $178,229 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 $178,229 31 Dec 2010 10-Q 14 Nov 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.